We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Internal Tourniquet Provides Deep Wound Hemorrhage Control

By HospiMedica International staff writers
Posted on 25 Jan 2010
An innovative device that is inserted into a bullet wound and then inflated to apply pressure directly along the bullet's path helps control blood loss. More...


The TourniCath device is a balloon tamponade designed to control exsanguinating hemorrhage that is not manageable by conventional external means such as direct pressure, clotting agents, bandages, and tourniquets. The device works by internal wound track compression using a cylindrical, doubled walled, inflatable balloon. The balloon is made of two wall layers of material: the outer wall is nylon coated on the inside with polyurethane; the inner wall is a layer of soft polyurethane. The design makes the balloon resistant to punctures from sharp objects, like shrapnel, that might be inside the wound, and also helps the balloon to conform to the shape of the wound and compress it.

Designed for wounds that produce profuse hemorrhage due to a deep penetrating trauma in the groin, pelvis, shoulder, or axilla areas, the TourniCath has a smooth rounded tip and a smooth outer sheath covering the rolled balloon. Once inserted into the wound track--through either the entry or the exit wounds-and the outer sheath removed, the balloon is then inflated to a pressure sufficient to tamponade internal bleeding (usually 90 mmHg to 150 mmHg). The maximum potential inflation volume of the cylindrical balloon is 400 mL, and the dimensions at maximum volume are 20 cm in length and 5 cm in diameter. The TourniCath is under development by CardioCommand (Tampa, FL, USA), and is not indicated for abdominal or thoracic wounds. The Tournicath Device is not currently approved by the US. Food and Drug Administration (FDA) and is therefore not available for sale in the United States.

Related Links:

CardioCommand





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gas Analyzer
GE SAM
New
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.